Investigative Site

Seattle, Washington 98109

0 studies enrolling now · 10 studies all time

What they study most

Constipation, Covid19, HIV I Infection, Heavy Menstrual Bleeding, Hereditary Hemochromatosis, Irritable Bowel Syndrome With Diarrhea (IBS-D), Menorrhagia, Opioid-induced Constipation, Overactive Bladder (OAB), Viral Hepatitis

Studies at this site

• A Study to Evaluate Tobevibart + Elebsiran in Chronic HDV Infection — Running, not enrolling
• Intramuscular and Intravenous VIR-7831 (Sotrovimab) for Mild/Moderate COVID-19. — Stopped early
• VIR-1111: A Prototype Human CMV-based Vaccine for Human Immunodeficiency Virus (HIV) in Healthy Volunteers — Completed
• VIR-7831 for the Early Treatment of COVID-19 in Outpatients — Completed
• A Study of LJPC-401 for the Treatment of Iron Overload in Adult Patients With Hereditary Hemochromatosis — Completed
• Efficacy, Safety and Tolerability of DNK333 (25 mg Bid) in Women With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) — Completed
• Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain. — Stopped early
• Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain — Stopped early
• Safety Study of XP12B in Women With Menorrhagia — Completed
• Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive Bladder — Completed